We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NDMA

News List

Statement from the FDA on NDMA found in drugs outside the US europeanpharmaceuticalreview
December 10, 2019
The FDA has released a statement on the investigations into the presence of nitrosamines in some drugs; highlighting that there are currently no recalls of metformin within the US.
Sandoz voluntarily recalls ranitidine over NDMA contamination concerns europeanpharmaceuticalreview
September 27, 2019
The probable carcinogen N-nitrosodimethylamine was detected in Sandoz’s ranitidine capsules, prompting the voluntary move.
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen drugs
September 20, 2019
Novartis, the maker of a generic form of Zantac, said Wednesday it will stop selling the medicine after investigations suggested that generic and branded versions contain a known carcinogen.
NDMA discovered in samples of ranitidine medicines europeanpharmaceuticalreview
September 17, 2019
The EMA and the FDA are investigating some ranitidine medicines after they were found to contain NDMA, a probable human carcinogen.
Zantac May Contain Small Amounts of Known Carcinogen drugs
September 16, 2019
A substance that could cause cancer has been found in some ranitidine heartburn and ulcer medicines, including the brand-name drug Zantac...

Previous page 1 2 3 4 Next page